Straumann stock reports 7.8 percent H1 organic growth

Published on 09/30/2026 at 09:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Straumann stock is backed by CHF 1,379.5 million in H1 2026 sales and 7.8 percent organic growth. Analysts set an average target of CHF 113.00.

Reinraum-Fertigung von Dentalimplantaten mit Ingenieuren an Präzisionsmaschinen — Straumann Holding AG (CH0012280076) betreibt moderne Reinraum-Fertigung für präzise Dentalimplantate in der Schweiz, Illustration mit AI erstellt.

Straumann stock is supported by CHF 1,379.5 million in first-half 2026 sales and 7.8 percent organic growth, while the company works through China pricing pressure and a leadership transition. According to StockSentinel on September 14, 2026, second-quarter organic growth accelerated to 8.5 percent.

Margins move higher

Core EBIT reached CHF 354.8 million in H1 2026, while the constant-currency core EBIT margin rose 120 basis points to 26.9 percent, according to StockSentinel. Core net profit increased 15.7 percent to CHF 262.0 million, and free cash flow rose 49 percent to CHF 168.6 million in the same half-year period.

The operating comparison matters because sales growth and margin expansion moved together. Management reaffirmed full-year 2026 guidance for high-single-digit organic growth and 140 to 170 basis points of core EBIT-margin expansion at constant 2025 exchange rates, as reported by StockSentinel.

Analysts see further upside

MarketScreener reported on September 23, 2026, that Bernstein kept an Outperform rating while raising its price target. The same page listed an average target of CHF 113.00, 16.23 percent above the CHF 97.22 last close, with 20 analysts included in the consensus.

That valuation debate is tied to execution rather than sales alone. China remains a central risk because volume-based procurement can reduce implant prices, while Straumann's iEXCEL platform, digital workflows and AXS ecosystem are intended to support account growth and recurring demand.

Next results arrive October 28

MarketScreener's calendar lists Straumann's Q3 2026 earnings release for October 28, 2026. The date gives investors a defined checkpoint for organic growth, margin delivery and the early effects of the incoming CEO transition.

On SIX Swiss Exchange, Straumann was last at CHF 94.12 on September 30, 2026 at 9:12 a.m. CEST. The stock's 52-week range was CHF 73.02 to CHF 109.80, and its market capitalization was CHF 15.0 billion on the same date.